UK Markets closed

Ipsen S.A. (IPSEF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
88.500.00 (0.00%)
At close: 03:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close88.50
Open88.50
Bid0.00 x 0
Ask0.00 x 0
Day's range88.50 - 88.50
52-week range88.50 - 121.03
Volume2
Avg. volume0
Market cap7.301B
Beta (5Y monthly)0.81
PE ratio (TTM)11.18
EPS (TTM)7.91
Earnings dateN/A
Forward dividend & yield1.28 (1.44%)
Ex-dividend date31 May 2022
1y target estN/A
  • Business Wire

    Ipsen Receives CHMP Negative Opinion for Palovarotene as a Treatment for Fibrodysplasia Ossificans Progressiva in E.U.

    PARIS, January 27, 2023--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended not to grant marketing authorization for investigational palovarotene as a treatment for the ultra-rare bone disease, fibrodysplasia ossificans progressiva (FOP). In the E.U. there are currently only symptomatic treatments for FOP, which do not reduce the formation of extra-skeletal bone i

  • Business Wire

    Ipsen Presents Phase III NAPOLI 3 Trial of Onivyde® Regimen Demonstrating Positive Survival Results in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma at ASCO GI

    PARIS, January 20, 2023--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today presented positive results from the pivotal Phase III NAPOLI 3 trial evaluating an investigational regimen of Onivyde® (irinotecan liposome injection), a long-circulating, liposomal topoisomerase inhibitor, in previously untreated patients with metastatic pancreatic ductal adenocarcinoma (mPDAC). In a late-breaking abstracts session presentation (LBA661) at the 2023 American Society of Clinical Oncology (ASCO) Gast

  • Motley Fool

    2 Tiny Nasdaq Stocks Making Major Merger Moves Monday

    The Nasdaq Composite (NASDAQINDEX: ^IXIC) might finally be looking to gain some momentum in 2023, with investors desperately wanting a reversal from 2022's horrible performance. Sizable gains on Friday helped to build more positive sentiment, and the bullish move continued on Monday morning, with the Nasdaq rising 1.5% at midmorning. Big-name companies get the headlines most of the time, but sometimes, news of mergers and acquisitions pushes a little-known company into the spotlight.